Feds seize Pharmaceutical Innovations' contaminated ultrasound gel

Pharmaceutical Innovations got smacked with a raid from the U.S. Marshals Service this week. According to CNN's coverage of the news, the agents seized the company's Other-Sonic Generic Ultrasound Transmission Gel, after the FDA said the product made 16 patients ill because it contained dangerous levels of bacteria. The FDA apparently took samples of the gel in February and found that they contained two strains of bacteria. Regulators asked for the law enforcement help as "a safety precaution," CNN said. Story | Learn more from FiercePharmaManufacturing

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.